Learning Objectives:

1. To evaluate if hypertension-associated progressive glomerulosclerosis is a significant driver of both de novo and all-cause chronic kidney disease leading to end-stage kidney failure.

2. To determine clinical significance of study results.

Session date: 
02/19/2021 - 12:00pm to 1:00pm CST
Zoom meeting
5700 S Maryland Ave
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Sri Mahathi Kalipatnapu, MD